Skip to main content
PMC home page
The Journal of Headache and Pain logoLink to The Journal of Headache and Pain
. 2008 Nov 22;10(1):27–34. doi: 10.1007/s10194-008-0082-2

Botulinum toxin: could it be an effective treatment for chronic tension-type headache?

Sherif M Hamdy 1, Hatem Samir 1,✉, M El-Sayed 1, Nermin Adel 1, Rasha Hasan 1
PMCID: PMC3451761  PMID: 19030947

Abstract

Several clinical trials suggest that botulinum toxin type-A (BTX-A) may be an effective treatment option for patients with chronic tension-type headache (CTTH); however, controversy remains as to how the botulinum toxin optimally should be used for treating headache and which patient's profile fits this treatment. The objective of this study was to evaluate the efficacy and tolerability of BTX-A for the prophylactic treatment of CCTH in Egyptian patients. This was a randomized, single-blind, placebo-controlled study of BTX-A for the treatment of patients aged 25–50 years old with CCTH. Following a 30-day screening, headache parameters and severity assessed by the standard visual analogue scale (VAS), and the 25-item Henry Ford Hospital Headache Disability Inventory (HDI) were recorded as a baseline. Then, injection was done with either BTX-A or with saline by a combination of two methods for detecting injection sites (the fixed-site approach and follow-the-pain approach). Our study showed significant improvement after 1 month of BTX-A injection regarding headache days/month, severity measured by VAS and HDI in headache severity. There was significant reduction of prophylactic medications, and there were minor complications, but these reversed spontaneously without further treatment. BTX-A was an effective and well-tolerated prophylactic treatment in Egyptian patients with CCTH.

Keywords: Botulinum toxin, Chronic tension-type headache, Prophylactic treatment

Full Text

The Full Text of this article is available as a PDF (243.0 KB).

Acknowledgments

Conflict of interest

None.

References

  • 1.Rozen D, Sharma J. Treatment of tension-type headache with botox: a review of the literature. Mt Sinai J Med. 2006;73(1):493–498. [PubMed] [Google Scholar]
  • 2.Araki N. Tension-type headache. Nippon Rinsho. 2005;63(10):1742–1746. [PubMed] [Google Scholar]
  • 3.International Headache Society Classification Subcommittee (2004) International classification of headache disorders, 2nd edn. Cephalalgia 24(suppl 1):1–160 [DOI] [PubMed]
  • 4.Mathew NT. Tension-type headache. Curr Neurol Neurosci Rep. 2006;6(2):100–105. doi: 10.1007/s11910-996-0031-x. [DOI] [PubMed] [Google Scholar]
  • 5.Ashina S, Bendtsen L, Ashina M. Pathophysiology of tension-type headache. Curr Pain Headache Rep. 2005;9(6):415–422. doi: 10.1007/s11916-005-0021-8. [DOI] [PubMed] [Google Scholar]
  • 6.Porta M. A comparative trial of botulinum toxin A and methylprednisolone for the treatment of tension-type headache. Curr Rev Pain. 2000;4:31–35. doi: 10.1007/s11916-000-0007-5. [DOI] [PubMed] [Google Scholar]
  • 7.Ates Y. Botulinum toxin for the treatment of headaches: a review of current practices and evidence based-data. Agri. 2006;18(3):5–11. [PubMed] [Google Scholar]
  • 8.Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM. Botulinum toxin type A (Botox) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg. 2000;123:669–676. doi: 10.1067/mhn.2000.110960. [DOI] [PubMed] [Google Scholar]
  • 9.Straube A, Empl M, Ceballos-Baumann A, Tolle T, Stefenelli U, Pfaffenrath V. Pericranial injection of botulinum toxin type A (Dysport) for tension-type headache—a multicentre, double-blind, randomized, placebo-controlled study. Eur J Neurol. 2008;15(3):205–213. doi: 10.1111/j.1468-1331.2007.02051.x. [DOI] [PubMed] [Google Scholar]
  • 10.Troost BT. Botulinum toxin A (Botox) in the treatment of migraine and other headaches. Expert Rev Neurother. 2004;4(1):27–31. doi: 10.1586/14737175.4.1.27. [DOI] [PubMed] [Google Scholar]
  • 11.Gobel H, Heinze A, Heinze-Kuhn K, Jost WH. Evidence-based medicine: botulinum toxin A in migraine and tension-type headache. J Neurol. 2001;248(Suppl 1):34–38. doi: 10.1007/PL00007818. [DOI] [PubMed] [Google Scholar]
  • 12.Schulte-Mattler WJ, Martinez-Castrillo JC. Botulinum toxin therapy of migraine and tension-type headache: comparing different botulinum toxin preparations. Eur J Neurol. 2006;13(Suppl 1):51–54. doi: 10.1111/j.1468-1331.2006.01445.x. [DOI] [PubMed] [Google Scholar]
  • 13.Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW. Treatment of headache with botulinum toxin A—a review according to evidence based criteria. Cephalalgia. 2002;22:699–710. doi: 10.1046/j.1468-2982.2002.00390.x. [DOI] [PubMed] [Google Scholar]
  • 14.Wheeler AH. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension. Headache. 1998;38:468–471. doi: 10.1046/j.1526-4610.1998.3806468.x. [DOI] [PubMed] [Google Scholar]
  • 15.Rollnik JD, Karst M, Fink M, Dengler R. Botulinum toxin Type A and EMG: a key to the understanding of chronic tension-type headaches? Headache. 2001;41(10):985–989. doi: 10.1046/j.1526-4610.2001.01193.x. [DOI] [PubMed] [Google Scholar]
  • 16.Durham PL, Cady R, Cady R. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache. 2004;44:35–43. doi: 10.1111/j.1526-4610.2004.04007.x. [DOI] [PubMed] [Google Scholar]
  • 17.Blumenfeld AJ. Botulinum toxin type A: a neuromodulatory mechanism of action in migraine (commentary) Headache. 2004;44:42–43. doi: 10.1111/j.1526-4610.2004.04154.x. [DOI] [Google Scholar]
  • 18.Dressler D, Saberi FA, Barbosa ER. Botulinum toxin: mechanisms of action. Arq Neuropsiquiatr. 2005;63:180–185. doi: 10.1590/s0004-282x2005000100035. [DOI] [PubMed] [Google Scholar]
  • 19.Scott J, Huskisson EC. Graphic representation of pain. Pain. 1976;2:175–184. doi: 10.1016/0304-3959(76)90113-5. [DOI] [PubMed] [Google Scholar]
  • 20.Jacobson GP, Ramadan NM, Aggarwal SK, Newman CW. The Henry Ford Hospital Headache Disability Inventory (HDI) Neurology. 1994;44:837–842. doi: 10.1212/wnl.44.5.837. [DOI] [PubMed] [Google Scholar]
  • 21.Mathew N, Kallasam K, Meadors L. Disease modification in chronic migraine with botulinum toxin type-A-long term experience. Headache. 2002;42:389–463. doi: 10.1046/j.1526-4610.2002.t01-1-04250.x. [DOI] [Google Scholar]
  • 22.Blumenfeld A. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders. Headache. 2003;43(8):853–860. doi: 10.1046/j.1526-4610.2003.03163.x. [DOI] [PubMed] [Google Scholar]
  • 23.Evers R, Vollmer-Haase J, Schwaag S, Rahmann A, Husstedt IW, Frese A. Botulinum toxin A in the prophylactic treatment of migraine—a randomized, double-blind, placebo-controlled study. Cephalalgia. 2004;24:838–843. doi: 10.1111/j.1468-2982.2004.00754.x. [DOI] [PubMed] [Google Scholar]
  • 24.Ashkenazi A, Silberstein S. Botulinum toxin type A for the treatment of headache: why we say yes. Arch Neurol. 2008;65(1):146–149. doi: 10.1001/archneurol.2007.20. [DOI] [PubMed] [Google Scholar]
  • 25.Martin-Araguz A, Garrido-Carrion A, Fernandez-Armayor V (2007) Prophylaxis of chronic daily headache with a simplified regimen of subcutaneous administration of botulinum toxin type A. Rev Neurol 45(7):385–388. (Abstract). Spanish [PubMed]
  • 26.Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C, BOTOX CDH study group Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache. 2005;45(4):293–307. doi: 10.1111/j.1526-4610.2005.05066.x. [DOI] [PubMed] [Google Scholar]
  • 27.Suzuki K, Iizuka T, Sakai F. Botulinum toxin type A for migraine prophylaxis in the Japanese population: an open-label prospective trial. Intern Med. 2007;46(13):959–963. doi: 10.2169/internalmedicine.46.6416. [DOI] [PubMed] [Google Scholar]
  • 28.Kemal Erdemoglu A, Varlibas A. The long-term efficacy and safety of botulinum toxin in refractory chronic tension-type headache. J Headache Pain. 2007;8(5):294–300. doi: 10.1007/s10194-007-0414-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Eross EJ, Gladstone JP, Lewis S, Rogers R, Dodick DW. Duration of migraine is a predictor for response to botulinum toxin type A. Headache. 2005;45(4):308–314. doi: 10.1111/j.1526-4610.2005.05067.x. [DOI] [PubMed] [Google Scholar]
  • 30.Schulte-Mattler WJ, Leinisch E. Evidence based medicine on the use of botulinum toxin for headache disorders. J Neural Transm. 2008;115(4):647–651. doi: 10.1007/s00702-007-0832-3. [DOI] [PubMed] [Google Scholar]
  • 31.Relja M, Telarovic S. Botulinum toxin in tension-type headache. J Neurol. 2004;251(Suppl 1):12–14. doi: 10.1007/s00415-004-1104-x. [DOI] [PubMed] [Google Scholar]
  • 32.Smuts JA, Baker MK, Smuts HM, Rossouw E, DeGryse RE, Barnard PWA.Prophylactic treatment of chronic tension-type headache using botulinum toxin type A Eur J Neurol 19996Suppl 499–102. 10.1111/j.1468-1331.1999.tb00044.x10209358 [DOI] [Google Scholar]
  • 33.Padberg M, Bruijn SF, Haan RJ, Tavy DL. Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia. 2004;24(8):675–680. doi: 10.1111/j.1468-2982.2004.00738.x. [DOI] [PubMed] [Google Scholar]
  • 34.Schmitt WJ, Slowey E, Fravi N, Weber S, Burgunder JM. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache. 2001;41(7):658–664. doi: 10.1046/j.1526-4610.2001.041007658.x. [DOI] [PubMed] [Google Scholar]
  • 35.Ewans RW, Blumenfeld A. Botulinum toxin injections for headache. Headache. 2003;43:682–685. doi: 10.1046/j.1526-4610.2003.03115.x. [DOI] [PubMed] [Google Scholar]
  • 36.Menezes C, Rodrigues B, Magalhaes E, Melo A. Botulinum toxin type A in refractory chronic migraine. An open-label trial. Arq Neuropsiquiatr. 2007;65(3-A):596–598. doi: 10.1590/s0004-282x2007000400009. [DOI] [PubMed] [Google Scholar]
  • 37.Klapper JA, Mathew NT, Klapper A, Kailasam J. Botulinum toxin type A (Btx-A) for the prophylaxis of chronic daily headache. Cephalalgia. 2000;20:292–293. doi: 10.1046/j.1468-2982.2000.00079.x. [DOI] [Google Scholar]
  • 38.Robbins L. Botulinum toxin A for refractory chronic daily headache. Neurology. 2001;56(Suppl 3):A349. [Google Scholar]
  • 39.Ondo WG, Vuong KD, Derman HS. Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study. Cephalalgia. 2004;24(1):60–65. doi: 10.1111/j.1468-2982.2004.00641.x. [DOI] [PubMed] [Google Scholar]
  • 40.Silberstein SD, Stark SR, Lucas SM, Christie SN, Degryse RE, Turkel CC, BoNTA-039 Study Group Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc. 2005;80(9):1126–1137. doi: 10.4065/80.9.1126. [DOI] [PubMed] [Google Scholar]
  • 41.Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Headache. 2007;47(4):486–499. doi: 10.1111/j.1526-4610.2006.00624.x. [DOI] [PubMed] [Google Scholar]
  • 42.Liu Y-C, Fuh J-L, Chen R-C, Lin K-P, Wang S-J. Botulinum toxin Type A in the prophylactic treatment of transformed migraine in Taiwanese patients: a review of 30 consecutive cases. J Chin Med Assoc. 2007;70(12):535–540. doi: 10.1016/S1726-4901(08)70056-X. [DOI] [PubMed] [Google Scholar]
  • 43.Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache. 2003;43(Suppl):9–15. doi: 10.1046/j.1526-4610.43.7s.3.x. [DOI] [PubMed] [Google Scholar]
  • 44.Mauskop A. The use of botulinum toxin in the treatment of headaches. Curr Pain Headache Rep. 2002;6:320–323. doi: 10.1007/s11916-002-0054-1. [DOI] [PubMed] [Google Scholar]
  • 45.Relja MA. Treatment of tension-type headache with botulinum toxin: 1-year follow-up. Cephalalgia. 2000;20:336. [Google Scholar]
  • 46.Mathew NT, Kailasam J, Meadors L. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache. Headache. 2008;48(2):194–200. doi: 10.1111/j.1526-4610.2007.00914.x. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Headache and Pain are provided here courtesy of BMC

RESOURCES